Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-27), M1 Kliniken AG's 14-Day RSI is 36.05.
The industry rank for M1 Kliniken AG's 14-Day RSI or its related term are showing as below:
HAM:M12's 14-Day RSI is ranked better than 83.33% of 126
companies
in the Medical Distribution industry
Industry Median: 48.58
vs HAM:M12: 36.05
M1 Kliniken AG (HAM:M12) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
M1 Kliniken AG 14-Day RSI Related Terms
HAM:M12 vs MCK, COR, CAH: 14-Day RSI Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG 14-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG (HAM:M12) has a 14-Day RSI of 36.05 as of Jul. 27, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on M1 Kliniken AG and its competitors. According to the industry distribution chart, M1 Kliniken AG ranks #21 out of 126 companies in the Medical Distribution industry, placing it in the top 16.7%.
Is M1 Kliniken AG's 14-Day RSI too high?
M1 Kliniken AG's current 14-Day RSI is 36.05. The Medical Distribution industry median 14-Day RSI is 48.58. M1 Kliniken AG's value of 36.05 is 25.8% below this industry median. Based on the distribution chart, M1 Kliniken AG ranks #21 out of 126 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's 14-Day RSI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #21 out of 126 companies for 14-Day RSI. This places M1 Kliniken AG in the top 17% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 48.58. M1 Kliniken AG's value of 36.05 is 25.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Distribution company?
The median 14-Day RSI among Medical Distribution companies is 48.58, based on 126 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current 14-Day RSI of 36.05 is 25.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median 14-Day RSI is 48.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current 14-Day RSI is 36.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, M1 Kliniken AG (HAM:M12) is currently considered Fairly Valued. The stock's GF Value™ is €15.68, compared to a current price of €16.88 — trading 7.7% above its estimated fair value. The current 14-Day RSI is 36.05 and 25.8% below the Medical Distribution industry median of 48.58. M1 Kliniken AG's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For M1 Kliniken AG (HAM:M12), the current 14-Day RSI is 36.05 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (HAM:M12) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of €16.88 is trading 7.7% above its estimated GF Value™ of €15.68.
GuruFocus considers M1 Kliniken AG to be Fairly Valued.
Key valuation signals for HAM:M12:
14-Day RSI: 36.05
GF Value™: €15.68 vs. price of €16.88 (7.7% above fair value)
Industry Position: 25.8% below the Medical Distribution median (#21 of 126)
No single metric tells the full story. See the HAM:M12 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
91GF Score
Get the complete analysis for HAM:M12
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:M12 has been successfully added to your 
